193 related articles for article (PubMed ID: 17590173)
1. Expression of autoimmune regulator gene (AIRE) and T regulatory cells in human thymomas.
Scarpino S; Di Napoli A; Stoppacciaro A; Antonelli M; Pilozzi E; Chiarle R; Palestro G; Marino M; Facciolo F; Rendina EA; Webster KE; Kinkel SA; Scott HS; Ruco L
Clin Exp Immunol; 2007 Sep; 149(3):504-12. PubMed ID: 17590173
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune regulator expression in thymomas with or without autoimmune disease.
Liu Y; Zhang H; Zhang P; Meng F; Chen Y; Wang Y; Yao Y; Qi B
Immunol Lett; 2014 Sep; 161(1):50-6. PubMed ID: 24768600
[TBL] [Abstract][Full Text] [Related]
3. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG.
Suzuki E; Kobayashi Y; Yano M; Fujii Y
Autoimmunity; 2008 Aug; 41(5):377-82. PubMed ID: 18568643
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1).
Ströbel P; Murumägi A; Klein R; Luster M; Lahti M; Krohn K; Schalke B; Nix W; Gold R; Rieckmann P; Toyka K; Burek C; Rosenwald A; Müller-Hermelink HK; Pujoll-Borrell R; Meager A; Willcox N; Peterson P; Marx A
J Pathol; 2007 Apr; 211(5):563-571. PubMed ID: 17334980
[TBL] [Abstract][Full Text] [Related]
5. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
6. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.
Wolff AS; Kärner J; Owe JF; Oftedal BE; Gilhus NE; Erichsen MM; Kämpe O; Meager A; Peterson P; Kisand K; Willcox N; Husebye ES
J Immunol; 2014 Oct; 193(8):3880-90. PubMed ID: 25230752
[TBL] [Abstract][Full Text] [Related]
7. The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond.
Marx A; Hohenberger P; Hoffmann H; Pfannschmidt J; Schnabel P; Hofmann HS; Wiebe K; Schalke B; Nix W; Gold R; Willcox N; Peterson P; Ströbel P
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S266-72. PubMed ID: 20859117
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity?
Offerhaus GJ; Schipper ME; Lazenby AJ; Montgomery E; Morsink FH; Bende RJ; Musler AR; van Lier RA; van Noesel CJ
Immunol Lett; 2007 Nov; 114(1):31-7. PubMed ID: 17928069
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the immune system in thymic malignancies.
Weksler B; Lu B
J Thorac Oncol; 2014 Sep; 9(9 Suppl 2):S137-42. PubMed ID: 25396311
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
Fujii Y; Hayakawa M; Inada K; Nakahara K
Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
[TBL] [Abstract][Full Text] [Related]
11. Late-onset myasthenia gravis - CTLA4(low) genotype association and low-for-age thymic output of naïve T cells.
Chuang WY; Ströbel P; Bohlender-Willke AL; Rieckmann P; Nix W; Schalke B; Gold R; Opitz A; Klinker E; Inoue M; Müller-Hermelink HK; Saruhan-Direskeneli G; Bugert P; Willcox N; Marx A
J Autoimmun; 2014 Aug; 52():122-9. PubMed ID: 24373506
[TBL] [Abstract][Full Text] [Related]
12. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
[TBL] [Abstract][Full Text] [Related]
13. Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis.
Marx A; Kirchner T; Greiner A; Müller-Hermelink HK; Schalke B; Osborn M
Lancet; 1992 Mar; 339(8795):707-8. PubMed ID: 1372058
[TBL] [Abstract][Full Text] [Related]
14. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Th-POK and Runx3 in T cell development in human thymoma.
Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M
Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737
[TBL] [Abstract][Full Text] [Related]
16. Thymoma and paraneoplastic myasthenia gravis.
Marx A; Willcox N; Leite MI; Chuang WY; Schalke B; Nix W; Ströbel P
Autoimmunity; 2010 Aug; 43(5-6):413-27. PubMed ID: 20380583
[TBL] [Abstract][Full Text] [Related]
17. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
[TBL] [Abstract][Full Text] [Related]
18. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
Chan JK; Tsang WY; Seneviratne S; Pau MY
Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
[TBL] [Abstract][Full Text] [Related]
19. [Expression of CD20 in thymomas and its clinical implication].
Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
[TBL] [Abstract][Full Text] [Related]
20. Aire and Foxp3 expression in a particular microenvironment for T cell differentiation.
Hansenne I; Louis C; Martens H; Dorban G; Charlet-Renard C; Peterson P; Geenen V
Neuroimmunomodulation; 2009 Jan; 16(1):35-44. PubMed ID: 19077444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
